PRO-Pharmasp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-09-23
Share capital
5,000.00 PLN
Registered address
ul. Obornicka 117, 62-002 Suchy Las, Poland
Electronic delivery address
AE:PL-88989-25822-EJTBR-19

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 54 days early.

  • 202508/06/2026
  • 202429/05/2025
  • 202313/05/2024
  • 202215/06/2023
  • 202122/06/2022
  • 202016/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 53.04kMedianUSD 66.59kAverageUSD 1.19m
Net profit
This companyUSD -322.57MedianUSD 1.80kAverageUSD 66.86k
Operating costs
This companyUSD 51.05kMedianUSD 50.38kAverageUSD 1.01m
Assets
This companyUSD 72.46kMedianUSD 69.63kAverageUSD 2.60m

Authorized Representatives

Aleksandra Słomka – President of the Management Board
Dariusz Leszek Baryła – Attorney-in-fact

Manner of representation

In the case of a one-person management board, the President of the Management Board is independently authorised to make declarations of will and sign on behalf of the company; in the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations of will and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Interpharma Ltd, Sutton Surrey, 4 St.barnabas Road, Sm1 4nl, United Kingdom
50$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-05-05.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$147
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$185

Competitors

Name
Kamińsko21sp. z o.o.
Z3 Groupsp. z o.o.
Mkmjsp. z o.o.
Lidlsp. z o.o.
LYX Groupsp. z o.o.
Home SellerS.K.A.
Kwartz InvestmentsS.A.
BF Consulting 2sp. z o.o.
Skład Handlowy Szczepańscysp. z o.o.
Wiercenia i Cięcia Chlebanowskisp. z o.o.

Change history

DateEvent
2016-06-29Address change
2016-06-29PKD change
2015-01-30Address change
2015-01-30PKD change
2014-09-23Entered in the register

FAQ

Last updated: 2026-10-07